Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL PHARMACIE SAINTE BARBE : revenue, balance sheet and financial ratios

SPFPL PHARMACIE SAINTE BARBE is a French company founded 6 years ago, specialized in the sector Gestion de fonds. Based in GURMENCON (64400), this company of category PME shows in 2025 a net income positive of 165 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL PHARMACIE SAINTE BARBE (SIREN 880038393)
Indicator 2025 2024 2023 2022 2021
Revenue N/C N/C N/C N/C N/C
Net income 164 575 € 295 432 € 163 547 € 148 998 € -4 833 €
EBITDA N/C -2 725 € -2 587 € -623 € -4 833 €
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SPFPL PHARMACIE SAINTE BARBE generates positive net income of 165 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

164 575 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 98%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.003%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

98.065%

Solvency indicators evolution
SPFPL PHARMACIE SAINTE BARBE

Sector positioning

Debt ratio
0.0 2025
2023
2024
2025
Q1: 0.0
Med: 11.05
Q3: 95.39
Excellent

In 2025, the debt ratio of SPFPL PHARMACIE SAINTE BARBE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
98.06% 2025
2023
2024
2025
Q1: 9.39%
Med: 52.08%
Q3: 89.29%
Excellent

In 2025, the financial autonomy of SPFPL PHARMACIE SAINTE BARBE (98.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2024
2023
2024
Q1: -0.01 years
Med: 0.0 years
Q3: 3.01 years
Good

In 2024, the repayment capacity of SPFPL PHARMACIE SAINTE BARBE (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 116439.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

116439.409

Liquidity indicators evolution
SPFPL PHARMACIE SAINTE BARBE

Sector positioning

Liquidity ratio
116439.41 2025
2023
2024
2025
Q1: 117.65
Med: 590.18
Q3: 4189.62
Excellent

In 2025, the liquidity ratio of SPFPL PHARMACIE SAINTE BARBE (116439.41) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2024
2023
2024
Q1: -71.24x
Med: 0.0x
Q3: 0.0x
Good

In 2024, the interest coverage of SPFPL PHARMACIE SAINTE BARBE (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL PHARMACIE SAINTE BARBE

Positioning of SPFPL PHARMACIE SAINTE BARBE in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (40 transactions). This range of 213 675€ to 1 231 416€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2025
Indicative
213k€ 421k€ 1231k€
421 472 € Range: 213 675€ - 1 231 416€
NAF 5 année 2025

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 40 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare SPFPL PHARMACIE SAINTE BARBE with other companies in the same sector:

Frequently asked questions about SPFPL PHARMACIE SAINTE BARBE

What is the revenue of SPFPL PHARMACIE SAINTE BARBE ?

The revenue of SPFPL PHARMACIE SAINTE BARBE is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL PHARMACIE SAINTE BARBE profitable?

Yes, SPFPL PHARMACIE SAINTE BARBE generated a net profit of 165 k€ in 2025.

Where is the headquarters of SPFPL PHARMACIE SAINTE BARBE ?

The headquarters of SPFPL PHARMACIE SAINTE BARBE is located in GURMENCON (64400), in the department Pyrenees-Atlantiques.

Where to find the tax return of SPFPL PHARMACIE SAINTE BARBE ?

The tax return of SPFPL PHARMACIE SAINTE BARBE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL PHARMACIE SAINTE BARBE operate?

SPFPL PHARMACIE SAINTE BARBE operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.